Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1989-11-22
1992-10-20
Rollins, John W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C07H 1700
Patent
active
051571153
ABSTRACT:
The inhibition or control of expression of IL-2 or IL-2.alpha. genes, and the inhibition or control of fundamental cellular processes responsible for retroviral replication, in particular HIV-I and HTLV-I DNA molecules, are disclosed. The invention is directed to nucleic acids or nucleic acid compositions which competitively bind regions of the IL-2 or IL-2.alpha. genes corresponding to their respective transcription factors. DNA or RNA fragments spanning the following regions in the IL-2 gene are shown to be effective; -195 to -204; -115 to -164; and -165 to -222. DNA or RNA fragments spanning the following regions in the IL-2.alpha. gene are shown to be effective: -62 to -71; and -32 to -86. Compositions comprising combinations of these fragments are also disclosed.
REFERENCES:
T. Fujita, et al., "Structure of the human interleukin 2 gene" Proc. Natl. Acad. Sci 80:7437, 1983.
T. Fujita, et al., "Regulation of human interleukin-2 gene" Cell, 46:401-407, 1986.
Bohnlein et al., The Same Inducible Nuclear Proteins Regulates Mitogen Activation of Both the Interleukin-2 Receptor-Alpha Gene and Type 1 HIV, Cell, 53:827-836 (1988).
Cross et al., Regulation of the Human Interleukin-2 Receptor.alpha. Chain Promoter: Activation of a Nonfunctional Promoter by the Transactivator Gene of HTLV-1, Cell, 49:47-56 (1987).
Leung et al., HTLV-1 Transactivator Induces Interleukin-2 Receptor Expression Through An NF-kB-Like Factor, Nature, 333:776-778 (1988).
Maruyama et al., Evidence for Aberrant Activation of the Interleukin-2 Autocrine Loop by HTLV-1 Encoded p40.sup.x and T3/Ti Complex Triggering, Cell, 48:343-350 (1987).
Miyatake et al., Activation of T Cell-Derived Lymphokine Genes in T Cells and Fibroblasts: Effects of Human T Cell Leukemia Virus Type I p40.sup.x Protein . . . , Nucleic Acid Research, 16:(14)6547-6566 (1988).
Nabel et al., An Inducible Transcription Factor Activates Expression of Human Immunodeficiency Virus in T Cells, Nature, 326:711-713 (1987).
Shaw et al., Identification of a Putative Regulator of Early T Cell Activation Genes, Science, 241:202-205 (1988).
Siekevitz et al., Activation of the HIV-1 by T Cell Mitogens and the Trans-Activator Protein of HTLV-I, Science, 328:1575-1578 (1987).
Siekevitz et al., Activation of Interleukin 2 and Interleukin 2 Receptor (Tac) Promoter Expression by the Trans-activator (Tat) Gene Product of Human . . . , Proc. Natl. Acad. Sci. USA, 84:5389-5393 (1987).
Stein et al., Antisense Compounds: Potential Role in Cancer Therapy, Important Adv. Oncol., (U.S.A.), pp. 79-97 (1989).
Siebenlist, V. et al., Mol. Cell. Biol. 6:3042-3049 (1986).
Franza, Jr., B. R. et al., Nature 330: 391-395 (1987).
The European Search Report for the corresponding European application No. 89121590.7.
LandOfFree
Regulation of expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192983